Global Activated Polyethylene Glycol (PEG) Market Insights, Forecast to 2028

Global Activated Polyethylene Glycol (PEG) Market Insights, Forecast to 2028

Market Analysis and Insights: Global Activated Polyethylene Glycol (PEG) Market
Due to the COVID-19 pandemic, the global Activated Polyethylene Glycol (PEG) market size is estimated to be worth US$ 230.00 million in 2022 and is forecast to a readjusted size of US$ 937.14 million by 2028 with a CAGR of 26.38% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Linear PEGs accounting for 58.00% of the Activated Polyethylene Glycol (PEG) global market in 2021, is projected to value US$ 537.71 million by 2028, growing at a revised 26.16% CAGR from 2022 to 2028. While Pharmaceutical Industry segment is altered to an 26.95% CAGR throughout this forecast period.
The global key manufacturers of Activated Polyethylene Glycol (PEG) include NOF, JenKem Technology, Nektar Therapeutics, Dr. Reddy's Laboratories, Merck, Chemgen Pharma, SINOPEG, SunBio, and Laysan Bio, etc. In 2021, the global top five players hold a share approximately 76.93% in terms of revenue.
In terms of production side, this report researches the Activated Polyethylene Glycol (PEG) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Activated Polyethylene Glycol (PEG) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Activated Polyethylene Glycol (PEG) Scope and Segment
Activated Polyethylene Glycol (PEG) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Activated Polyethylene Glycol (PEG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
NOF
JenKem Technology
Nektar Therapeutics
Dr. Reddy's Laboratories
Merck
Chemgen Pharma
SINOPEG
SunBio
Laysan Bio
Creative PEGWorks

Segment by Type
Linear PEGs
Branched PEGs
Multi-Arm PEGs
Others

Segment by Application
Pharmaceutical Industry
Medical Equipment
Others

Production by Region
North America
Europe
China
Japan
South Korea

Sales by Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
SEA

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil
Argentina

Middle East & Africa
Middle East
Africa